glp-1 drugs for weight loss side effects The Agonists and Obesity: How Diabetes are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 medications have changed the

Study: Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy

These are the people who separate themselves from your typical influencers and wellness grifters precisely because they follow the science before they open their mouths

Gastric distention by balloon and test-meal intake in obese and lean subjects

'If you find a compound in venom that changes how cells metabolise sugar, it's a promising thing

We propose a pathway divided into three sequential stages: Intensive phase (metabolic optimization): for those planning pregnancy within 612 months, GLP-1RAs can be used for 36 months of intensive weight loss (using a 5%10% reduction as an actionable threshold), while simultaneously improving background risks such as IR, MASLD, and lipid profiles

"We believe the launch of Saxenda represents a significant contribution to the therapeutic options that are advancing obesity care